Home Categories API Methazolamide
A1307450

Methazolamide , 98% , 554-57-4

Synonym(s):
N-(4-Methyl-2-sulfamoyl-Δ2-1,3,4-thiadiazolin-5-ylidene) acetamide;5-Acetylimino-4-methyl-·2-1,3,4-thiadiazoline-2-sulfonamide;Methazolamide;N-[5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide;N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide, Carbonic Anhydrase Inhibitor, Methazolamide, CAIX Inhibitor III

CAS NO.:554-57-4

Empirical Formula: C5H8N4O3S2

Molecular Weight: 236.27

MDL number: MFCD00083416

EINECS: 209-066-7

Pack Size Price Stock Quantity
250mg RMB175.20 In Stock
1g RMB263.20 In Stock
5g RMB952.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 208 °C (dec.) (lit.)
Boiling point: 402.0±28.0 °C(Predicted)
Density  1.6625 (rough estimate)
refractive index  1.6270 (estimate)
storage temp.  2-8°C
solubility  DMSO: soluble20mg/mL, clear
pka 7.30(at 25℃)
form  White powder
color  white to beige
Water Solubility  2.835g/L(25 ºC)
InChIKey FLOSMHQXBMRNHR-QPJJXVBHSA-N
CAS DataBase Reference 554-57-4(CAS DataBase Reference)
NIST Chemistry Reference Methazolamide(554-57-4)
EPA Substance Registry System Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]- (554-57-4)

Description and Uses

Methazolamide is a carbonic anhydrase inhibitor (IC50 = 130 nM). It reduces intraocular pressure and cerebrospinal fluid flow in a rat model of glaucoma. Methazolamide reduces electroshock-induced seizures in rats with an ED50 value of 19.2 mg/kg. It also inhibits production of reactive oxygen species (ROS) in a primary cortical neuron (PCN) cellular model of subarachnoid hemorrhage (SAH) and reduces cerebral edema in a mouse model of SAH. Methazolamide is larvicidal, with a larvicidal concentration (LC50) value of 724 ppm, but has no activity when administered in the diet to adult A. aegypti. Formulations containing methazolamide have been used for the treatment of glaucoma.

Action of this drug is similar to that of acetazolamide, and it is used for lowering intraocular pressure in treating wide-angle and secondary glaucoma, and before surgical intervention for severe wide-angle glaucoma.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Warning
Hazard statements  H302+H312+H332-H351
Precautionary statements  P201-P280-P301+P312-P302+P352+P312-P304+P340+P312-P308+P313
Hazard Codes  Xn
Risk Statements  20/21/22-40
Safety Statements  22-36
WGK Germany  3
RTECS  AC6350000
HS Code  2935904000
Hazardous Substances Data 554-57-4(Hazardous Substances Data)

RELATED PRODUCTS